arrow
Back
K

Kjetil Taskén

oslo university hospital

69H-index
415Paper Count
1.7WCitation Count
Published Papers 174
Publication Date
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T Cells
err2026-04-03
err0
errOAAI
errQian Wei; Ehsan Hajjar; Selma Cornillot-Clément; Elise Solli; Nuria García-Díaz; Johannes Landskron; Alexandra Gade; Rafi Ahmad; Kjetil Taskén
errShare
errSave
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
err2026-01-22
err0
errOAAI
errElise Solli; Alessio Bevilacqua; Mathias Wenes; Denis Migliorini; Lars van der Veen; Sigrid S Skånland; Giusy Di Conza; Kjetil Taskén
errShare
errSave
A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium
err2025-11-06
err0
errOAAI
errS.F. Haj Mohammad; H. van der Pol; E. Vrdoljak; U. Lassen; K. Ojamaa; K. Jalkanen; L. Verlingue; A. Stenzinger; A. Patócs; G. Curigliano; E. Baltruškevičienė; Å. Helland; H.G. Russnes; I. Ługowska; B. Mainoli; A. Edsjö; E. Lonardi; K. Taskén; H. Gelderblom
errShare
errSave
Targeting proteostasis in multiple myeloma through inhibition of LTK
errLeukemia
IF13.4
err2025-07-09
err0
errOAAI
errThea Kristin Våtsveen; Mariaserena Giliberto; Valgerdur Bjornsdottir; Federica Centonze; Andrej Besse; Yannick Frey; Sigrid S. Skånland; Anders Tveita; Amin Alirezaylavasani; John Franklin Imbery; Kristine Misund; Veronika Reiterer; Muhammad Zahoor; Christoph Driessen; Lenka Besse; Kjetil Tasken; Fredrik H. Schjesvold; Hesso Farhan; Ludvig A. Munthe
errShare
errSave
The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency
err2025-01-06
err0
errOAAI
errPosadas-Cantera, Sara; Mitsuiki, Noriko; Emmerich, Florian; Patino, Virginia; Lorenz, Hanns-Martin; Neth, Olaf; Dybedal, Ingunn; Tasken, Kjetil; Schaffer, Alejandro A.; Grimbacher, Bodo; Gamez-Diaz, Laura
errShare
errSave
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways
err2024-09-08
err0
errOAAI
errBischof, Katharina; Cremaschi, Andrea; Eroukhmanoff, Lena; Landskron, Johannes; Flage-Larsen, Lise-Lotte; Gade, Alexandra; Bjorge, Line; Urbanucci, Alfonso; Tasken, Kjetil
errShare
errSave
PRIME-ROSE: Merging clinical outcome data from DRUP-like clinical trials
err2024-09-01
err0
PREAI
errKringelbach, T. M.; Fagereng, L.; Mohammad, S. F. Haj; Verbeek, F.; Timmer, H. J. L.; Juslin, T.; Verlingue, L.; Krebs, M. G.; Blay, J-Y.; Jalkanen, K.; Rohrberg, K. S.; Lassen, U. N.; Helland, A.; Verheul, H. M. W.; Voest, E. E.; Gelderblom, H.; Tasken, K.
errShare
errSave
Evolutionary mode and timing of dissemination of high-grade serous carcinomas
err2024-01-04
err0
errOAAI
errSveen, Anita; Johannessen, Bjarne; Klokkerud, Solveig M. K.; Kraggerud, Sigrid M.; Meza-Zepeda, Leonardo A.; Bjornslett, Merete; Bischof, Katharina; Myklebost, Ola; Tasken, Kjetil; Skotheim, Rolf I.; Dorum, Anne; Davidson, Ben; Lothe, Ragnhild A.
errShare
errSave
Standardized assays to monitor drug sensitivity in hematologic cancers
err2023-12-01
err5
errOAAI
errAyuda-Duran, Pilar; Hermansen, Johanne U.; Giliberto, Mariaserena; Yin, Yanping; Hanes, Robert; Gordon, Sandra; Kuusanmaki, Heikki; Brodersen, Andrea M.; Andersen, Aram N.; Tasken, Kjetil; Wennerberg, Krister; Enserink, Jorrit M.; Skanland, Sigrid S.
errShare
errSave
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
err2023-11-30
err5
errOAAI
errSpasevska, Ivana; Sharma, Ankush; Steen, Chloe B.; Josefsson, Sarah E.; Blaker, Yngvild N.; Kolstad, Arne; Rustad, Even H.; Meyer, Saskia; Isaksen, Kathrine; Chellappa, Stalin; Kushekhar, Kushi; Beiske, Klaus; Forsund, Mette S.; Spetalen, Signe; Holte, Harald; Ostenstad, Bjorn; Brodtkorb, Marianne; Kimby, Eva; Olweus, Johanna; Tasken, Kjetil; Newman, Aaron M.; Lorenz, Susanne; Smeland, Erlend B.; Alizadeh, Ash A.; Huse, Kanutte; Myklebust, June H.
errShare
errSave
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
err2023-11-01
err1
errOAAI
errLe Tourneau, Christophe; Andre, Fabrice; Helland, Aslaug; Mileshkin, Linda; Minnaard, Warnyta; Schiel, Anja; Tasken, Kjetil; Thomas, David M.; Veronese, Maria Luisa; Duran-Pacheco, Gonzalo; Leyens, Lada; Rufibach, Kaspar; Thomas, Marlene; Kraemer, Alwin
errShare
errSave
The DRUP-like clinical trials family: A distributed European trial network for equitable access to precision medicine
err2023-10-01
err2
errOAAI
errGelderblom, H.; Edsjo, A.; Russnes, H. E. G.; Lassen, U. N.; Helland, A.; Hult, E. Hallersjo; Ryll, B.; Lugowska, I.; Blay, J-Y.; Falk, R. S.; van Doorn-Khosrovani, S. van Waalwijk; Carlsson, K. Steen; Peltola, K.; Stenzinger, A.; Vrdoljak, E.; Oliveira, J.; Mohammad, S. F. Haj; Verheul, H. M. W.; Voest, E. E.; Tasken, K.
errShare
errSave
Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure
err2023-04-18
err7
PREAI
errSkogestad, Jonas; Albert, Ingrid; Hougen, Karina; Lothe, Gustav B.; Lunde, Marianne; Eken, Olav Sovik; Veras, Ioanni; Huynh, Ngoc Trang Thi; Borstad, Mira; Marshall, Serena; Shen, Xin; Louch, William E.; Robinson, Emma Louise; Cleveland, Joseph C.; Ambardekar, Amrut V.; Schwisow, Jessica A.; Jonas, Eric; Calejo, Ana I.; Morth, Jens Preben; Tasken, Kjetil; Melleby, Arne Olav; Lunde, Per Kristian; Sjaastad, Ivar; Carlson, Cathrine Rein; Aronsen, Jan Magnus
errShare
errSave
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
err2023-04-13
err10
errOAAI
errHermansen, Johanne U.; Yin, Yanping; Urban, Aleksandra; Myklebust, Camilla V.; Karlsen, Linda; Melvold, Katrine; Tveita, Anders A.; Tasken, Kjetil; Munthe, Ludvig A.; Tjonnfjord, Geir E.; Skanland, Sigrid S.
errShare
errSave
Cross Talk between Phosphatidylinositol 3-Kinase and Cyclic AMP (cAMP)-Protein Kinase A Signaling Pathways at the Level of a Protein Kinase B/β-Arrestin/cAMP Phosphodiesterase 4 Complex
err2023-03-20
err62
errOAAI
errBjorgo, Elisa; Solheim, Silje A.; Abrahamsen, Hilde; Baillie, George S.; Brown, Kim M.; Berge, Torunn; Okkenhaug, Klaus; Houslay, Miles D.; Tasken, Kjetil
errShare
errSave
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
err2023-03-01
err6
errOAAI
errKohn-Luque, Alvaro; Myklebust, Even Moa; Tadele, Dagim Shiferaw; Giliberto, Mariaserena; Schmiester, Leonard; Noory, Jasmine; Harivel, Elise; Arsenteva, Polina; Mumenthaler, Shannon M.; Schjesvold, Fredrik; Tasken, Kjetil; Enserink, Jorrit M.; Leder, Kevin; Frigessi, Arnoldo; Foo, Jasmine
errShare
errSave
Cross Talk between Phosphatidylinositol 3-Kinase and Cyclic AMP (cAMP)-Protein Kinase A Signaling Pathways at the Level of a Protein Kinase B/b-Arrestin/cAMP Phosphodiesterase 4 Complex (vol 30, pg 1660, 2010)
err2023-02-27
err0
errOAAI
errBjorgo, Elisa; Solheim, Silje A.; Abrahamsen, Hilde; Baillie, George S.; Brown, Kim M.; Berge, Torunn; Okkenhaug, Klaus; Houslay, Miles D.; Tasken, Kjetil
errShare
errSave
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
err2022-11-29
err4
errOAAI
errGiliberto, Mariaserena; Santana, Leonardo Miranda; Holien, Toril; Misund, Kristine; Nakken, Sigve; Vodak, Daniel; Hovig, Eivind; Meza-Zepeda, Leonardo A.; Coward, Eivind; Waage, Anders; Tasken, Kjetil; Skanland, Sigrid S.
errShare
errSave
Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models
err2022-11-01
err7
errOAAI
errFlobak, Asmund; Skanland, Sigrid S.; Hovig, Eivind; Tasken, Kjetil; Russnes, Hege G.
errShare
errSave